Dr Garth Baynam

Professor Gareth Baynam is a practicing clinical geneticist, genomic policy advisor, clinician scientist and intrapreneur with expertise in rare disease, Indigenous health, precision phenotyping, digital health and health system implementation.

Prof Baynam is an internationally recognised expert in transformational rare diseases research, clinical implementation (including leading state-wide health service implementations of omics and digital health technologies), and related health policy.

Prof Baynam also leads a 3D facial analysis research group with a resultant research, software tools and collaborative ecosystem deployed across 4 continents. Prof Baynam is a co-founder of the Undiagnosed Diseases Network International which globally integrates more than 140 leading clinical academic centres with programs supported multiple National Institutes of Health, or their equivalents.

Prof Baynam has Chaired multiple international multi-stakeholder Taskforces (e.g. via International Rare Diseases Research Consortium) on rare diseases, the outputs have helped to coordinate and shape international research and clinical practice.

CI Baynam has published > 150 peer reviewed publications, and 3 book chapters in genetic and rare diseases, clinical informatics, policy, multi-stakeholder consultation and implementation.

In the last 5 years, he has had first or senior authorship in Cell and Nature Genetics (x2) and an author in Nature, Nature Reviews Drug Discovery (x2), Nature Reviews Genetics(x2). H-index 39, citations >7000.
 

Lyfe Languages – Indigenous Youth driven Universal Indigenous Medical Translator
Cliniface – unlocking facial clues for diagnosis, care, treatment and clinical trial monitoring
INNOVaTR – INNOvative Therapies and trials for Rare diseases
CaRelink – linking rare diseases diagnosis through to treatment, care and support
Treatments for those that have none – delivering novel therapies for children with rare diseases
 

MBBS, DCH, FRACP, PHD, A/FAIDH
 

• Minister’s Award, WA Health – 2019
• Finalist Premier’s Science Award. 2018 (Cliniface)
• Lifetime Award Genetic and Rare Diseases Network, WA, 2019
• Finalist WA Health Awards, Service Innovation
• Asia-Pacific Spatial Excellence Award, 2020 (Cliniface)
• Finalist, Incite WA innovation Award, 2021 (Lyfe Languages)
• Finalist, Digital Disruptor Award, 2021 (Lyfe Languages)
• Finalist, iAwards, 2021 (Lyfe Languages)